A/Prof Jim Jackson is an experienced, supportive radiation oncologist who is committed to delivering prompt, personalised cancer treatment for those in his care. He is passionate about cutting-edge radiation therapy and maintains an active involvement in clinical research to deliver the best possible outcome for his patients.
A/Prof Jim Jackson is an experienced radiation oncologist at Icon Cancer Centre Gold Coast, Icon Cancer Centre North Lakes and Icon Cancer Centre Greenslopes. In 2004 he graduated from the University of Queensland with a Bachelor of Medicine, Bachelor of Surgery (MBBS). A/Prof Jackson has also completed a Bachelor of Arts in Psychology at the University of California, Los Angeles (UCLA) and a PhD investigating methods to reduce side effects of cancer treatment at Monash University.
A/Prof Jackson completed his radiation oncology training in Queensland and in 2012, he undertook a clinical research fellowship at the Austin-Olivia Newton-John Cancer and Wellness Centre in image guided and intensity modulated radiation therapy (IMRT). In January 2014 he joined Icon Cancer Centre Gold Coast bringing expertise in state-of-the-art treatment techniques including stereotactic radiation therapy for lung and brain tumours. He enjoys teaching medical students and is a research supervisor for radiation oncology trainees and university students. He holds appointments as Honorary Adjunct Associate Professor at Bond University and Senior Lecturer in Medicine at Griffith University.
A/Prof Jackson is a member of the Icon Cancer Centre Research Committee and has held several roles with the Royal Australia and New Zealand College of Radiologists (RANZCR) at a national level. In October 2016 he served as scientific co-convenor for the RANZCR Annual Scientific Meeting, at the Gold Coast Exhibition and Convention Centre. He is a member of both the American and European Radiation Oncology Societies and regularly reviews scientific papers for national and international medical journals.
His clinical experience covers a broad range of malignancies with a special interest in brain cancer, head and neck cancer, gynaecological cancer, genitourinary cancer, lung cancer, skin cancer and breast cancer.